1. Home
  2. AGIO vs JJSF Comparison

AGIO vs JJSF Comparison

Compare AGIO & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$31.82

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo J & J Snack Foods Corp.

JJSF

J & J Snack Foods Corp.

HOLD

Current Price

$77.92

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
JJSF
Founded
2007
1971
Country
United States
United States
Employees
N/A
1800
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
AGIO
JJSF
Price
$31.82
$77.92
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$38.88
$140.00
AVG Volume (30 Days)
856.4K
183.2K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
3.67%
EPS Growth
N/A
N/A
EPS
N/A
0.13
Revenue
$43,011,000.00
$1,022,038,000.00
Revenue This Year
$76.75
$0.30
Revenue Next Year
$170.73
$1.70
P/E Ratio
N/A
$612.08
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$68.87
52 Week High
$46.00
$129.24

Technical Indicators

Market Signals
Indicator
AGIO
JJSF
Relative Strength Index (RSI) 62.62 54.69
Support Level $26.71 $73.60
Resistance Level $36.07 $88.12
Average True Range (ATR) 1.52 2.31
MACD 0.29 0.66
Stochastic Oscillator 97.47 63.72

Price Performance

Historical Comparison
AGIO
JJSF

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.

Share on Social Networks: